Home Cart Sign in  
Chemical Structure| 70-00-8 Chemical Structure| 70-00-8

Structure of Trifluridine
CAS No.: 70-00-8

Chemical Structure| 70-00-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Trifluorothymidine is a derivative of thymidine that can inhibit thymidylate synthase and lead to DNA damage and apoptosis. It could be used to treat colorectal cancer.

Synonyms: Trifluorothymidine; TFT; 2-Deoxy-5-trifluoromethyluridine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Trifluridine

CAS No. :70-00-8
Formula : C10H11F3N2O5
M.W : 296.20
SMILES Code : O=C1NC(C(C(F)(F)F)=CN1[C@@H]2O[C@H](CO)[C@@H](O)C2)=O
Synonyms :
Trifluorothymidine; TFT; 2-Deoxy-5-trifluoromethyluridine
MDL No. :MFCD00006534
InChI Key :VSQQQLOSPVPRAZ-RRKCRQDMSA-N
Pubchem ID :6256

Safety of Trifluridine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • DNA synthesis

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 p53-R175H and p53-R248Q cells 3 μM 60 h To assess FTD's effect on p53-GOF mutant cells, demonstrating FTD induced aberrant mitosis and apoptosis, phenotypically similar to p53-KO cells. PMC11219725
HCT116 p53-KO cells 3 μM 48-72 h To evaluate the effect of FTD on cell cycle in p53-KO cells, showing FTD induced DNA double-stranded breaks, ssDNA accumulation, and G2 phase DNA damage responses, leading to chromosome breaks and aberrant mitosis. PMC11219725
SW48 cells 8.1 μM(IC50) 72 h To evaluate the in vitro antiproliferative effects of panitumumab and FTD combination. Results showed that cotreatment with panitumumab and FTD produced synergistic antiproliferative effects in SW48 cells. PMC5537908
LIM1215 cells 0.57 μM(IC50) 72 h To evaluate the in vitro antiproliferative effects of panitumumab and FTD combination. Results showed that cotreatment with panitumumab and FTD produced additive antiproliferative effects in LIM1215 cells. PMC5537908

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02943733 Neuroendocrine Tumors ... More >> Neoplasms Cancer Tumors Less << Phase 1 Recruiting August 2020 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect    800-622-8922    cancerconnect@uwcarbone.wisc.edu    Principal Investigator: Nataliya Uboha Less <<
NCT01916447 Advanced Gastrointestinal Tumo... More >>rs Less << Phase 1 Completed - United States, California ... More >> Los Angeles Clinical Site Los Angeles, California, United States, 90095 United States, Illinois Chicago Clinical Site Chicago, Illinois, United States, 60611 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37212 Less <<
NCT01904253 Small Cell Lung Cancer (SCLC) Phase 2 Terminated(The preliminary dat... More >>a does not suggest any safety signal, but an ad hoc interim analysis showed an imbalance of PFS between the two arms) Less << - Germany ... More >> Klinikum Mannheim GmbH Universitaetsklinikum Mannheim, Baden-Württemberg, Germany Lungenklinik Heckeshorn- HELIOS Kliniken GmbH Berlin, Germany LungenClinic Grosshansdorf Grosshansdorf, Germany Klinikum Koeln-Merheim Koplin, Germany St. Hildegardis-Krankenhaus- Katholisches Klinikum Mainz Mainz, Germany LMU-Campus Innenstadt Muenchen, Germany Italy Azienda Ospedaliero-Universitaria S. Luigi Gonzaga Orbassano, Turin, Italy IRCCS Centro di Riferimento Oncologico di Aviano, Divisione Oncologia Medica A Aviano, Italy Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari Bari, Italy Azienda Ospedaliera Univ. Policlinico Gaspare Rodolico Catania, Italy Azienda Ospedaliera Instituti Ospitalieri di Cremona Cremona, Italy Azienda Ospedaliera Universitaria Careggi Firenze, Italy IEO Istituto Europeo di Oncologia Milano, Italy Azienda Ospedaliera San Gerardo U.O Oncologia Medica Monza, Italy Arcispedale S. Maria Nuova Azienda Ospedaliera di Reggio Emilia Reggio Emilia, Italy A.O.V.V. Ospedale Eugenio Morelli-Sondalo Sondalo, Italy Japan National Cancer Center Hospital East Chiba, Japan, 277-8577 National Kyushi Cancer Center Fukuoka, Japan, 811-1395 Hyogo Cancer Center Hyogo, Japan, 673-8588 Saitama Cancer Center Saitama, Japan, 362-0806 Shizuoka Cancer Center Shizuoka, Japan, 411-8777 Nippon Medical School Hospital Tokyo, Japan, 113-8603 Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo, Japan, 135-8550 Less <<
NCT02860546 Refractory Metastatic Colorect... More >>al Cancer Less << Phase 2 Completed - United States, Colorado ... More >> Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT03686488 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Gastric Cancer Less << Phase 2 Recruiting January 1, 2023 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Neal Shah    813-745-1393    Neal.Shah@moffitt.org Less <<
NCT01896856 Previously Treated Metastatic ... More >>Colorectal Cancer Less << Phase 2 Recruiting September 2019 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Anthony El-Khoueiry, MD    323-865-3967    elkhouei@med.usc.edu    United States, Maryland Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Ellen Lilly-Foreman, RN    443-287-4961    lillyel@jhmi.edu    Contact: Tearra Miles       tlawre18@jhmi.edu    Principal Investigator: Nilo Azad, MD          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Derek Alexander    646-888-1381    alexandd@mskcc.org    Principal Investigator: Andrea Cercek, MD          Netherlands VU Medisch Centrum Recruiting Amsterdam, Netherlands, 1081 HV Contact: Henk Verheul, MD       h.verheul@vumc.nl    Contact: Elske Gootjes, MD       e.gootjes@vumc.nl Less <<
NCT01874522 Advanced Solid Tumors (Excludi... More >>ng Breast Cancer) Less << Phase 1 Completed - United States, Arizona ... More >> Scottsdale Healthcare Scottsdale, Arizona, United States, 85258 Less <<
NCT02031055 Advanced Solid Tumors Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsbutgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02613221 Colorectal Cancer Phase 1 Phase 2 Completed - Japan ... More >> Nagoya, Aichi, Japan Kashiwa, Chiba, Japan Matsuyama, Ehime, Japan Kitakyushu, Fukuoka, Japan Kurume, Fukuoka, Japan Hakodate, Hokkaido, Japan Kushiro, Hokkaido, Japan Sapporo, Hokkaido, Japan Amagasaki, Hyogo, Japan Kobe, Hyogo, Japan Tsukuba, Ibaragi, Japan Kasama, Ibaraki, Japan Miki-cho, Kagawa, Japan Sagamihara, Kanagawa, Japan Osaki, Miyagi, Japan Matsumoto, Nagano, Japan Sasebo, Nagasaki, Japan Yamatotakada, Nara, Japan Takatsuki, Osaka, Japan Ina, Saitama, Japan Shizuoka, Shizioka, Japan Nagaizumi, Shizuoka, Japan Kouto-ku, Tokyo, Japan Minato-ku, Tokyo, Japan Chiba, Japan Fukui, Japan Fukuoka, Japan Kumamoto, Japan Okayama, Japan Okinawa, Japan Osaka, Japan Toyama, Japan Less <<
NCT02848079 Colorectal Neoplasms Phase 1 Phase 2 Recruiting December 2020 United States, Connecticut ... More >> Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06510 Contact: Jeremy Kortansky, MD       Jeremy.kortmansky@yale.edu    Contact: Kamil Sadowski       kamil.sadowski@yale.edu Less <<
NCT02654639 - Terminated(Principal investiga... More >>tor left the institution) Less << - -
NCT03520946 Colorectal Cancer Phase 2 Not yet recruiting June 1, 2021 Germany ... More >> Klinikum Altenburger Land GmbH Not yet recruiting Altenburg, Germany, 04600 Contact: Armin Schulz-Abelius, Dr.          MVZ Gesundheitszentrum St. Marien GmbH Not yet recruiting Amberg, Germany, 922241 Contact: Ludwig Fischer von Weikersthal, Dr.          HELIOS Klinikum Bad Saarow Not yet recruiting Bad Saarow, Germany, 15526 Contact: Daniel Pink, Dr.          Charité - Universitätsmedizin Berlin Campus Mitte Not yet recruiting Berlin, Germany, 10115 Contact: Susen Burock, Dr.          MVZ Seestrasse Not yet recruiting Berlin, Germany, 13347 Contact: Alexander Schmittel, Dr.          St.-Johannes-Hospital Not yet recruiting Dortmund, Germany, 44137 Contact: Volker Hagen, Dr.          Universitätsklinikum Düsseldorf Not yet recruiting Düsseldorf, Germany, 40225 Contact: Dirk Graf, Prof. Dr.          Universitätsklinikum Essen Not yet recruiting Essen, Germany, 45147 Contact: Stefan Kasper, Prof. Dr.          Krankenhaus Nordwest GmbH Not yet recruiting Frankfurt, Germany, 60488 Contact: Thorsten O Goetze, PD Dr.          Universitätsklinikum Hamburg-Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Alexander Stein, Prof. Dr.          Medizinische Hochschule Hannover Not yet recruiting Hannover, Germany, 30625 Contact: Arndt Vogel, Prof. Dr.          Vincentius-Diakonissen-Kliniken gAG Not yet recruiting Karlsruhe, Germany, 76137 Contact: Alexander Kolov, Dr.          Universitätsklinikum Leipzig Not yet recruiting Leipzig, Germany, 04103 Contact: Albrecht Hoffmeister, Prof. Dr.          Klinikum Ludwigsburg Not yet recruiting Ludwigsburg, Germany, 71640 Contact: Stefan Angermeier, Dr.          Tagestherapiezentrum am ITM Universitätsmedizin Mannheim Not yet recruiting Mannheim, Germany, 68167 Contact: Ralf D Hofheinz, Prof. Dr.          Johannes Weslin Klinikum Minden Not yet recruiting Minden, Germany, 32429 Contact: Hans J Tischler, Dr.          Kliniken Maria Hilf GmbH Not yet recruiting Mönchengladbach, Germany, 41063 Contact: Ullrich Graeven, Prof. Dr.          Klinikum der Universität München-Großhadern Not yet recruiting München, Germany, 81377 Contact: Volker Heinemann, Prof. Dr.          Klinikum Nürnberg Not yet recruiting Nürnberg, Germany, 90419 Contact: Gabriele Siegler, Dr.          Studienzentrum Onkologie Ravensburg Not yet recruiting Ravensburg, Germany, 88212 Contact: Tobias Dechow, Prof. Dr.          Leopoldina Krankenhaus Not yet recruiting Schweinfurt, Germany, 97422 Contact: Stephan Kanzler, Prof. Dr.          MVZ Klinik Dr. Hancken GmbH Not yet recruiting Stade, Germany, 21680 Contact: Johannes Meiler, Dr.          Klinikum Wilhelmshaven Not yet recruiting Wilhelmshaven, Germany, 26389 Contact: Tanja Trarbach, Dr.          Hämatologisch-Onkologische Praxis Not yet recruiting Würselen, Germany, 52146 Contact: Christoph Maintz, Dr. Less <<
NCT01867879 Advanced Solid Tumors (Excludi... More >>ng Breast Cancer) Less << Phase 1 Completed - United States, Tennessee ... More >> Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT02261532 Advanced or Metastatic Solid T... More >>umors Less << Phase 1 Completed - China ... More >> Taiho Pharmaceutical Co., Ltd selected site Beijing, China Less <<
NCT02654639 Metastatic Colorectal Cancer Phase 2 Terminated(Principal investiga... More >>tor left the institution) Less << - United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20007 Less <<
NCT02301104 Advanced Solid Tumors Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California Duarte Clinical Site Duarte, California, United States, 91010 Santa Monica Clinical Site Santa Monica, California, United States, 90404 United States, Maryland Baltimore Clinical Site Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston Clinical Site Boston, Massachusetts, United States, 02111 United States, Ohio Cleveland Clinical Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania Pittsburgh Clinical Site Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Dallas Clinical Site Dallas, Texas, United States, 75246 Less <<
NCT02301117 Advanced Solid Tumors Phase 1 Recruiting July 2019 United States, Arizona ... More >> Phoenix Clinical Site Completed Phoenix, Arizona, United States, 85054 United States, California Duarte Clinical Site Recruiting Duarte, California, United States, 91010 Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    Santa Monica Clinical Site Recruiting Santa Monica, California, United States, 90095 Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    United States, Florida Gainesville Clinical Site Recruiting Gainesville, Florida, United States, 32610 Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    United States, Maryland Baltimore Clinical Site Active, not recruiting Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston Clinical Site Recruiting Boston, Massachusetts, United States, 02111 Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    United States, Ohio Cleveland Clinical Site Completed Cleveland, Ohio, United States, 44106 Cleveland Clinical Site Completed Cleveland, Ohio, United States, 44195 United States, Pennsylvania Pittsburgh Clinical Site Completed Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Dallas Clinical Site Recruiting Dallas, Texas, United States, 75246 Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    Czechia Brno Clinical Site Recruiting Brno, Czechia Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    Praha Clinical Site Recruiting Praha, Czechia Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    Serbia Belgrade Clinical Site Recruiting Belgrade, Serbia, 11080 Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com    Sremska Kamenica Clinical Site Recruiting Sremska Kamenica, Serbia, 21204 Contact: Robert Winkler, MD    855-598-8259    rwinkler@taihooncology.com Less <<
NCT01955837 Colorectal Cancer Phase 3 Completed - China ... More >> Peking University Cancer Hospital Beijing, China, 100142 Fudan University Shanghai Cancer Center Shanghai, China, 200032 Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Thailand Chulalongkorn University & The King Chulalongkorn Memorial Hospital Bangkok, Thailand, 10330 Less <<
NCT02500043 Refractory Metastatic Gastric ... More >>Cancer Less << Phase 3 Completed - -
NCT02920476 Squamous Cell Lung Carcinoma Phase 2 Active, not recruiting July 30, 2021 United States, Florida ... More >> UF Health Cancer Center Gainesville, Florida, United States, 32608 Less <<
NCT03305913 Pretreated Metastatic Colorect... More >>al Cancer Less << Phase 1 Recruiting June 30, 2019 Germany ... More >> Universitätsmedizin Mainz, I.Medizinische Klinik und Poliklinik Recruiting Mainz, Germany, 55131 Contact: Markus Möhler, Prof. Dr. Less <<
NCT01607957 Colorectal Cancer Phase 3 Completed - -
NCT03190616 Colorectal Neoplasms Phase 2 Recruiting December 30, 2019 China, Jiangsu ... More >> the second hospital of Changzhou city Not yet recruiting Changzhou, Jiangsu, China, 213000 Contact: Hua Jiang, Dr.    008651981099988       Nanjing 81 Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yingxia Chen, Dr.          the first affiliated hospital with Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: xiaofeng chen, Dr.          Principal Investigator: Yanhong Gu, Dr          Jiangnan University affiliated hospital Not yet recruiting Wuxi, Jiangsu, China, 214000 Contact: Dong Hua, Dr.    008651088683114 Less <<
NCT02921737 Pancreatic Cancer Phase 2 Recruiting November 1, 2020 United States, Florida ... More >> Malcom Randall VA Medical Center Not yet recruiting Gainesville, Florida, United States, 32608 Contact: Allison Trainor, MPH          Principal Investigator: Dennie Jones, MD          UF Health Cancer Center Recruiting Gainesville, Florida, United States, 32608 Contact: Margaret Veal          Principal Investigator: Jennifer Duff, MD Less <<
NCT03274882 Metastatic Colorectal Cancer Phase 2 Phase 3 Active, not recruiting December 31, 2018 Russian Federation ... More >> Russian Cancer Research Center n.a. NN Blokhin (RCRC), Clinical Pharmacology and Chemotherapy department Moscow, Russian Federation, 115478 Saint Petersburg Clinical Scientific-Practical Center of Special Medical Care (Oncology Center) Saint Petersburg, Russian Federation, 197758 Less <<
NCT00081835 Vaccinia Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03762161 Bladder Cancer Phase 2 Not yet recruiting December 2023 United States, Kansas ... More >> University of Kansas Cancer Center - Clinical Research Center Not yet recruiting Fairway, Kansas, United States, 66208 Contact: kerry hepler    913-945-7552    ctnursenav@kumc.edu    Principal Investigator: Rahul Parikh, MD          University of Kansas Cancer Center, Westwood Campus Not yet recruiting Kansas City, Kansas, United States, 66205 Contact: Clinical Trials Nurse Navigator    913-945-7552    ctnursenav@kumc.edu    Principal Investigator: Rahul Parikh, MD Less <<
NCT00000138 Keratitis, Herpetic ... More >> Ocular Herpes Simplex Less << Phase 3 Unknown - -
NCT03324113 Neoplasm Malignant Phase 1 Active, not recruiting January 2019 Japan ... More >> Investigational Site Number 3920003 Kashiwa-Shi, Japan Investigational Site Number 3920002 Nagoya-Shi, Japan Investigational Site Number 3920001 Sunto-Gun, Japan Less <<
NCT02602327 Colon Cancer ... More >>Rectal Cancer Liver Metastases Less << Phase 1 Recruiting September 2020 United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Curt Johanson    415-353-2310    curt.johanson@ucsf.edu    Principal Investigator: Nicholas Fidelman, MD Less <<
NCT03317119 RAS Family Gene Mutation ... More >> Stage III Colon Cancer AJCC v7 Stage III Colorectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 Stage IIIA Colon Cancer AJCC v7 Stage IIIA Colorectal Cancer AJCC v7 Stage IIIA Rectal Cancer AJCC v7 Stage IIIB Colon Cancer AJCC v7 Stage IIIB Colorectal Cancer AJCC v7 Stage IIIB Rectal Cancer AJCC v7 Stage IIIC Colon Cancer AJCC v7 Stage IIIC Colorectal Cancer AJCC v7 Stage IIIC Rectal Cancer AJCC v7 Stage IV Colon Cancer AJCC v7 Stage IV Colorectal Cancer AJCC v7 Stage IV Rectal Cancer AJCC v7 Stage IVA Colon Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVA Rectal Cancer AJCC v7 Stage IVB Colon Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Stage IVB Rectal Cancer AJCC v7 Less << Phase 1 Recruiting December 2019 United States, California ... More >> City of Hope Corona Recruiting Corona, California, United States, 92879 Contact: Cheryl Corpus    626-256-4673 ext 81529       Principal Investigator: Misagh Karimi, MD          City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Marwan Fakih, MD    626-256-4673    mfakih@coh.org    Principal Investigator: Marwan Fakih, MD          City of Hope Antelope Valley Recruiting Lancaster, California, United States, 93534 Contact: Regan Johnson    626-256-4673 ext 25648       Principal Investigator: Mohammad Fekrazad, MD          City of Hope Mission Hills Recruiting Mission Hills, California, United States, 91345 Contact: Amy Shousha    626-256-4673 ext 81865       Principal Investigator: Suzy Melkonian, MD          City of Hope Rancho Cucamonga Recruiting Rancho Cucamonga, California, United States, 91730 Contact: Valerie Estala    626-256-4673 ext 81699       Principal Investigator: Behnam Ebrahimi, MD          City of Hope South Pasadena Recruiting South Pasadena, California, United States, 91030 Contact: Odessa Rodriguez    626-256-4673 ext 81409       Principal Investigator: Christina Yeon, MD          City of Hope West Covina Recruiting West Covina, California, United States, 91790 Contact: Meizi Zheng    626-256-4673 ext 81336       Principal Investigator: Gargi Upadhyaya, MD Less <<
NCT02848443 Metastatic Colorectal Cancer Phase 1 Recruiting December 2019 Austria ... More >> Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie Recruiting Wien, Austria France CHU Timone Recruiting Marseille, France Hôpital Saint Antoine Recruiting Paris, France Hôpital Universitaire Pitié Salpêtrière - Pavillon Antonin Gosset Recruiting Paris, France Centre Eugène Marquis Recruiting Rennes, France HIA Bégin Recruiting Saint Mandé, France Gustave Roussy Recruiting Villejuif, France Germany St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum Abteilung für Hämatologie und Onkologie Recruiting Bochum, Germany Universitaetsklinikum Hamburg-Eppendorf Hubertus Wald Tumorzentrum - UCCH Recruiting Hamburg, Germany Klinikum der Universität München Campus Großhadern, Medizinische Klinik und Poliklinik III Recruiting Munchen, Germany Universitätsklinikum Ulm, Zentrum für Innere Medizin, Klinik für Innere Medizin I Recruiting Ulm, Germany Klinikum Wolfsburg, Medizinische Klinik II Recruiting Wolfsburg, Germany Hungary Magyar Honvedseg Egeszsegugyi Kozpont Onkologiai Osztaly Recruiting Budapest, Hungary Orszagos Onkologiai Intezet "B" Belgyogyaszati-Onkologiai O. Es Klin. Farmakologiai O. Recruiting Budapest, Hungary Semmelweis Egyetem, I. sz. Belgyogyaszati Klinika - Klin. Farmakologiai Reszleg Recruiting Budapest, Hungary Italy ARNAS - Azienda Ospedaliera Garibaldi - Nesima Struttura Complessa di Oncologia Medica Recruiting Catania, Italy Ist.Scientifico Romagnolo per lo Studio e la Cura dei Tumori Department of Clinical Oncology Recruiting Meldola, Italy Poiclinico G.B. Rossi A.O.U.I. di Verona Recruiting Verona, Italy Spain ICO Badalona. H. Germans Trials y Pujol, Servicio de Oncología médica Recruiting Badalona, Spain Hospital Vall D'Hebron (VHIO) Recruiting Barcelona, Spain HOSPITAL UNIVERSITARIO GREGORIO MARAÑON Oncología Médica Recruiting Madrid, Spain Hospital Universitario Madrid Sanchinarro Recruiting Madrid, Spain Hospital Universitario Ramón y Cajal de Madrid Recruiting Madrid, Spain Hospital Clinico de Valencia Recruiting Valencia, Spain United Kingdom Christie Hospital NHS Foundation Trust GI & Endocrine Recruiting Manchester, United Kingdom Less <<
NCT03223779 Colorectal Cancer Phase 1 Phase 2 Recruiting January 31, 2025 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Theodore S. Hong, MD    617-724-8770    tshong1@mgh.harvard.edu    Principal Investigator: Theodore S. Hong, MD Less <<
NCT02743221 Metastatic Colorectal Cancer Phase 2 Active, not recruiting October 2019 -
NCT01867866 Advanced Solid Tumors Phase 1 Completed - United States, Texas ... More >> South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States, 78229 Less <<
NCT03031691 Metastatic Colorectal Cancer Phase 1 Completed - United States, Colorado ... More >> Denver Denver, Colorado, United States United States, Florida Miami Miami, Florida, United States Sarasota Sarasota, Florida, United States United States, South Carolina Charleston Charleston, South Carolina, United States United States, Tennessee Nashville Nashville, Tennessee, United States Less <<
NCT00002037 Mycobacterium Avium-Intracellu... More >>lare Infection|HIV Infections Less << COMPLETED - New York Hosp - Cornell Med Ct... More >>r, New York, New York, 10021, United States Less <<
NCT00000635 Herpes Simplex ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Ucsf Aids Crs San Francisco, California, United States United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States United States, Illinois Cook County Hosp. CORE Ctr. Chicago, Illinois, United States Northwestern University CRS Chicago, Illinois, United States Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287 United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Less <<
NCT03278106 Cholangiocarcinoma ... More >> Stage III Gallbladder Cancer AJCC v7 Stage IIIA Gallbladder Cancer AJCC v7 Stage IIIB Gallbladder Cancer AJCC v7 Stage IV Gallbladder Cancer AJCC v7 Stage IVA Gallbladder Cancer AJCC v7 Stage IVB Gallbladder Cancer AJCC v7 Less << Phase 2 Suspended(accrual has been met... More >>) Less << September 15, 2020 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03297710 Rectal Adenocarcinoma ... More >> Recurrent Rectal Carcinoma Stage IV Rectal Cancer AJCC v7 Stage IVA Rectal Cancer AJCC v7 Stage IVB Rectal Cancer AJCC v7 Less << Phase 1 Recruiting October 31, 2019 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Daniel H. Ahn          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Joleen M. Hubbard Less <<
NCT03717038 Metastatic Colorectal Cancer ... More >> Colorectal Cancer Metastatic Carcinoma Less << Phase 3 Not yet recruiting December 2025 -
NCT03368963 Colorectal Adenocarcinoma ... More >> Gastric Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Non-Resectable Cholangiocarcinoma Stage IV Colorectal Cancer Stage IV Gastric Cancer Stage IV Pancreatic Cancer Stage IVA Colorectal Cancer Stage IVB Colorectal Cancer Unresectable Pancreatic Carcinoma Less << Phase 1 Phase 2 Recruiting February 29, 2020 United States, Georgia ... More >> Emory University Hospital Midtown Recruiting Atlanta, Georgia, United States, 30308 Contact: Shabnam Montazeri    404-686-0242    shabnam.montazeri@emory.edu    Emory University Hospital/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Sheena Abraham    404-778-2670    sheena.abraham@emory.edu    Emory Saint Joseph's Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Alicia Escobar    678-843-7029    alicia.m.escobar@emory.edu Less <<
NCT03616574 Advanced or Metastatic Solid T... More >>umors Advanced or Metastatic Colorectal Cancer (mCRC) Less << Phase 1 Not yet recruiting June 2021 -
NCT03665506 - Recruiting June 2021 Germany ... More >> Onkologische Schwerpunktpraxis Kurfürstendamm Recruiting Berlin, Germany, 10707 Contact: Ingo Schwaner, MD    +49 30 887742570    ingo.schwaner@onkologie-kurfuerstendamm.de Less <<
NCT03306394 Metastatic Colorectal Cancer Phase 3 Recruiting May 2019 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.38mL

0.68mL

0.34mL

16.88mL

3.38mL

1.69mL

33.76mL

6.75mL

3.38mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories